|
Quotes & Info
|
| PGNX > SEC Filings for PGNX > Form 8-K on 8-Nov-2012 | All Recent SEC Filings |
8-Nov-2012
Results of Operations and Financial Condition, Financial Statements
Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced its operational results for the quarter and nine months ended September 30, 2012. A copy of its press release is included in this Report as Exhibit 99.1.
The information furnished pursuant to this Item 2.02 shall not be deemed to be "filed" for purposes of Section 18 of the U.S. Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section, unless we specifically incorporate it by reference in a document filed under the Exchange Act or the U.S. Securities Act of 1933. We undertake no duty or obligation to publicly update or revise the information so furnished.
(d) Exhibits
Exhibit No. Description
99.1 Press Release dated November 8, 2012.
|
|